Hound Partners, LLC Molecular Partners Ag Transaction History

Hound Partners, LLC

  • $307 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$18.34 - $21.0 $2.22 Million - $2.55 Million
-121,247 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$19.25 - $21.01 $2.33 Million - $2.55 Million
121,247 New
121,247 $2.48 Million

Others Institutions Holding MOLN

# of Institutions
6
Shares Held
849K
Call Options Held
0
Put Options Held
0
View Full List

About MOLECULAR PARTNERS AG

MOLN Quotes by TradingView
  • Ticker MOLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,514,000
  • Market Cap $169M
  • Description
  • Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...
More about MOLN
Track This Portfolio

Track Hound Partners, LLC Portfolio

Follow Hound Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hound Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hound Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email